Adeno-associated virus (AAV) vectors are among the most prominent viral vectors for in vivo gene therapy. Viral genome titer is a critical quality attribute in AAV characterization for safe and efficacious gene therapy products. Specificity of AAV vectors as well as the concentration of the vector titer must be determined throughout the production process and for final release testing.
The MiQuant® AAV kits have been developed for the determination of AAV vector titer. Different kit versions enable the specific detection of AAV genotype 2/6 (including genotype 1, 3 & 7) or genotype 5.
|
